Market Stimulus and Genomic Justice: Evaluating the Effects of Market Access to Human Germ-Line Enhancement

The concept of "market stimulus" the idea that free markers can play a role in widening access to new technologies may help support the view that parents should be permitted to purchase germ-line enhancements. However, a critical examination of the topic shows that market stimulus, even if it applies to human genomic interventions, does not provide sufficient reason for deregulating germ-line enhancements because: (I) it could widen the gap between the rich and the poor; (2) even if it does not widen the gap, it might not sufficiently benefit the poor; and (3) it could have harmful effects for future generations.